| BW Investor Alert: Babcock & Wilcox Enterprises Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Overstated Pipeline Metrics: Levi & Korsinsky |
Globe Newswire |
04/27 |
17:42 |
| Performance Shipping Inc. Announces Filing of 2025 Annual Report on Form 20-F |
Globe Newswire |
04/27 |
17:39 |
| ROSEN, A NATIONALLY RECOGNIZED INVESTOR RIGHTS LAW FIRM, Encourages Hercules Capital, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action– HTGC |
Globe Newswire |
04/27 |
17:38 |
| Biomea Fusion Announces Positive 52-Week Results from Phase 2 COVALENT-112 Trial in Type 1 Diabetes Showing C-Peptide Improvement and Durability Following 12-Weeks of Icovamenib Treatment |
Globe Newswire |
04/27 |
17:37 |
| Marathon record-breaker says he underwent strict testing regime before smashing 2-hour barrier |
AP Online |
04/27 |
17:31 |
| Crypto News: Pepeto Opens New Presale Stage Whilst Cardano Price Prediction Questions the $1 Target |
Globe Newswire |
04/27 |
17:30 |
| EOSE FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Eos Energy Enterprises, Inc. Investors to Secure Counsel Before Important May 5 Deadline in Securities Class Action – EOSE |
Globe Newswire |
04/27 |
17:23 |
| Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting |
Globe Newswire |
04/27 |
17:21 |
| Lexeo Therapeutics Announces Multiple Presentations at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting |
Globe Newswire |
04/27 |
17:15 |
| Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults |
Globe Newswire |
04/27 |
17:13 |
| APO Investor Alert: APOLLO GLOBAL MANAGEMENT, INC. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Claims Black Concealed Epstein Payments: Levi & Korsinsky |
Globe Newswire |
04/27 |
17:10 |
| UPST Investor Alert: Upstart Holdings Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Certified False AI Claims: Levi & Korsinsky |
Globe Newswire |
04/27 |
17:07 |
| Brown & Brown, Inc. announces first quarter 2026 results, including total revenues of $1.9 billion, an increase of 35.4%; flat Organic Revenue; growth of Organic Revenue with Contingents of 2.2%; diluted net income per share of $1.06; Diluted Net Income Per Share - Adjusted of $1.39; and a quarterly dividend of $0.165 per share |
Globe Newswire |
04/27 |
17:03 |
| Crypto News Today: Pepeto CoinMarketCap Listing Goes Live While BNB Price Prediction Points Toward $2,000 |
Globe Newswire |
04/27 |
17:00 |
| Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting |
Globe Newswire |
04/27 |
17:00 |
| North American Construction Group Ltd. First Quarter Results Conference Call and Webcast Notification |
Globe Newswire |
04/27 |
17:00 |
| Seven Goranson Bain Ausley Attorneys Named to D Magazine’s 2026 Best Lawyers in Dallas |
Globe Newswire |
04/27 |
17:00 |
| Arbor Biotechnologies to Present Expansion of CNS Editing Platform Capabilities at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting |
Globe Newswire |
04/27 |
17:00 |
| Auddia Announces Closing of $12 Million Public Offering |
Globe Newswire |
04/27 |
16:55 |
| BABCOCK & WILCOX CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urges Babcock & Wilcox Enterprises, Inc. Investors with Large Losses to Contact the Firm |
Globe Newswire |
04/27 |
16:52 |
| Tessera Therapeutics to Present New Preclinical Data Supporting In Vivo Program in Sickle Cell Disease and Advancements in In Vivo CAR-T Applications at the American Society of Gene and Cell Therapy 29th Annual Meeting |
Globe Newswire |
04/27 |
16:46 |
| First Bank Announces First Quarter 2026 Net Income of $7.6 Million |
Globe Newswire |
04/27 |
16:35 |
| Dyne Therapeutics Announces Upcoming Presentation Highlighting Robust CNS Activity in Nonhuman Primates with its FORCE™ Platform at 2026 ASGCT Annual Meeting |
Globe Newswire |
04/27 |
16:34 |
| Editas Medicine to Present New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at Upcoming Scientific Conferences |
Globe Newswire |
04/27 |
16:31 |
| Asgard Therapeutics announces oral presentation at ASGCT 2026, showcasing advanced preclinical data on AT-108 – its first-in-class, off-the-shelf, gene-based cancer immunotherapy |
Globe Newswire |
04/27 |
16:30 |
